Neurocrine Biosciences
NBIX
#1391
Rank
$12.70 B
Marketcap
$125.51
Share price
-1.18%
Change (1 day)
13.84%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

P/S ratio for Neurocrine Biosciences (NBIX)

P/S ratio as of November 2024 (TTM): 5.67

According to Neurocrine Biosciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.67. At the end of 2024 the company had a P/S ratio of 5.18.

P/S ratio history for Neurocrine Biosciences from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.18-24.49%
20236.86-11.06%
20227.718.2%
20217.13-16.75%
20208.56-31.97%
201912.6-12.4%
201814.4-66.18%
201742.5-81.05%
2016224-9.2%
2015247
2014N/A-100%
20132162204.11%
20129.3554.16%
20116.07-51.52%
201012.5-69.11%
200940.530.41%
200831.1-78.11%
20071421310.15%
200610.1-46.46%
200518.8-11.08%
200421.152.7%
200313.8-82.15%
200277.6105.49%
200137.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
14.0 146.93%๐Ÿ‡บ๐Ÿ‡ธ USA
6.84 20.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
5.22-7.79%๐Ÿ‡บ๐Ÿ‡ธ USA
19.0 235.75%๐Ÿ‡บ๐Ÿ‡ธ USA
5.50-2.98%๐Ÿ‡บ๐Ÿ‡ธ USA
2.72-51.97%๐Ÿ‡บ๐Ÿ‡ธ USA
2.33-58.82%๐Ÿ‡บ๐Ÿ‡ธ USA
10.4 83.82%๐Ÿ‡บ๐Ÿ‡ธ USA